Comparison of standard and hand-assisted laparoscopic radical nephrectomy for renal cell carcinoma.

Masahiko Harano, Masatoshi Eto, Akira Yokomizo, Katsunori Tatsugami, Masumitsu Hamaguchi, Seiji Naito

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A laparoscopic radical nephrectomy (LRN) for renal cancer can be performed using two methods, hand-assisted laparoscopic surgery (HALS) and standard laparoscopic surgery (SLS). This institute initially used HALS to perform all radical nephrectomy, but gradually shifted to SLS. This study compared the two methods of radical nephrectomy: HALS vs. SLS, which were performed at a single institute. From March 1999 to November 2006, a total 129 patients with pathologically confirmed renal cell carcinoma underwent LRN, including 73 patients with the HALS and 56 patients with SLS. The median operative time was 264 minutes, and median estimated blood loss was 200 ml in the HALS group, respectively. The median operative time and median estimated blood loss in the SLS were 215 minutes and 100 ml, respectively. There was no significant difference in either the operative time or estimated blood loss between HALS and SLS. The median time to both postoperative oral intake and ambulation in the SLS were 1 day. Neither of these events after SLS was significantly shorter than that after HALS. The 4-year disease-free and overall survival rates in the HALS patients were 97.5% and 98.2%, respectively. Both the 4-year disease-free and overall survival rates in the SLS patients were 100%. Since no significant differences were observed between the two operative methods (SLS and HALS) regarding the operative data, postoperative course and oncological outcome, the surgical method for LRN can be selected according to characteristics of each surgical method.

Original languageEnglish
Pages (from-to)389-396
Number of pages8
JournalFukuoka igaku zasshi = Hukuoka acta medica
Volume98
Issue number11
Publication statusPublished - Jan 1 2007

Fingerprint

Hand-Assisted Laparoscopy
Nephrectomy
Renal Cell Carcinoma
Laparoscopy
Hand
Operative Time
Disease-Free Survival
Survival Rate
Kidney Neoplasms
Walking

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Comparison of standard and hand-assisted laparoscopic radical nephrectomy for renal cell carcinoma. / Harano, Masahiko; Eto, Masatoshi; Yokomizo, Akira; Tatsugami, Katsunori; Hamaguchi, Masumitsu; Naito, Seiji.

In: Fukuoka igaku zasshi = Hukuoka acta medica, Vol. 98, No. 11, 01.01.2007, p. 389-396.

Research output: Contribution to journalArticle

@article{3705b9f3b2ac4709a51931ac633a70c3,
title = "Comparison of standard and hand-assisted laparoscopic radical nephrectomy for renal cell carcinoma.",
abstract = "A laparoscopic radical nephrectomy (LRN) for renal cancer can be performed using two methods, hand-assisted laparoscopic surgery (HALS) and standard laparoscopic surgery (SLS). This institute initially used HALS to perform all radical nephrectomy, but gradually shifted to SLS. This study compared the two methods of radical nephrectomy: HALS vs. SLS, which were performed at a single institute. From March 1999 to November 2006, a total 129 patients with pathologically confirmed renal cell carcinoma underwent LRN, including 73 patients with the HALS and 56 patients with SLS. The median operative time was 264 minutes, and median estimated blood loss was 200 ml in the HALS group, respectively. The median operative time and median estimated blood loss in the SLS were 215 minutes and 100 ml, respectively. There was no significant difference in either the operative time or estimated blood loss between HALS and SLS. The median time to both postoperative oral intake and ambulation in the SLS were 1 day. Neither of these events after SLS was significantly shorter than that after HALS. The 4-year disease-free and overall survival rates in the HALS patients were 97.5{\%} and 98.2{\%}, respectively. Both the 4-year disease-free and overall survival rates in the SLS patients were 100{\%}. Since no significant differences were observed between the two operative methods (SLS and HALS) regarding the operative data, postoperative course and oncological outcome, the surgical method for LRN can be selected according to characteristics of each surgical method.",
author = "Masahiko Harano and Masatoshi Eto and Akira Yokomizo and Katsunori Tatsugami and Masumitsu Hamaguchi and Seiji Naito",
year = "2007",
month = "1",
day = "1",
language = "English",
volume = "98",
pages = "389--396",
journal = "Fukuoka Acta Medica",
issn = "0016-254X",
publisher = "福岡医学会",
number = "11",

}

TY - JOUR

T1 - Comparison of standard and hand-assisted laparoscopic radical nephrectomy for renal cell carcinoma.

AU - Harano, Masahiko

AU - Eto, Masatoshi

AU - Yokomizo, Akira

AU - Tatsugami, Katsunori

AU - Hamaguchi, Masumitsu

AU - Naito, Seiji

PY - 2007/1/1

Y1 - 2007/1/1

N2 - A laparoscopic radical nephrectomy (LRN) for renal cancer can be performed using two methods, hand-assisted laparoscopic surgery (HALS) and standard laparoscopic surgery (SLS). This institute initially used HALS to perform all radical nephrectomy, but gradually shifted to SLS. This study compared the two methods of radical nephrectomy: HALS vs. SLS, which were performed at a single institute. From March 1999 to November 2006, a total 129 patients with pathologically confirmed renal cell carcinoma underwent LRN, including 73 patients with the HALS and 56 patients with SLS. The median operative time was 264 minutes, and median estimated blood loss was 200 ml in the HALS group, respectively. The median operative time and median estimated blood loss in the SLS were 215 minutes and 100 ml, respectively. There was no significant difference in either the operative time or estimated blood loss between HALS and SLS. The median time to both postoperative oral intake and ambulation in the SLS were 1 day. Neither of these events after SLS was significantly shorter than that after HALS. The 4-year disease-free and overall survival rates in the HALS patients were 97.5% and 98.2%, respectively. Both the 4-year disease-free and overall survival rates in the SLS patients were 100%. Since no significant differences were observed between the two operative methods (SLS and HALS) regarding the operative data, postoperative course and oncological outcome, the surgical method for LRN can be selected according to characteristics of each surgical method.

AB - A laparoscopic radical nephrectomy (LRN) for renal cancer can be performed using two methods, hand-assisted laparoscopic surgery (HALS) and standard laparoscopic surgery (SLS). This institute initially used HALS to perform all radical nephrectomy, but gradually shifted to SLS. This study compared the two methods of radical nephrectomy: HALS vs. SLS, which were performed at a single institute. From March 1999 to November 2006, a total 129 patients with pathologically confirmed renal cell carcinoma underwent LRN, including 73 patients with the HALS and 56 patients with SLS. The median operative time was 264 minutes, and median estimated blood loss was 200 ml in the HALS group, respectively. The median operative time and median estimated blood loss in the SLS were 215 minutes and 100 ml, respectively. There was no significant difference in either the operative time or estimated blood loss between HALS and SLS. The median time to both postoperative oral intake and ambulation in the SLS were 1 day. Neither of these events after SLS was significantly shorter than that after HALS. The 4-year disease-free and overall survival rates in the HALS patients were 97.5% and 98.2%, respectively. Both the 4-year disease-free and overall survival rates in the SLS patients were 100%. Since no significant differences were observed between the two operative methods (SLS and HALS) regarding the operative data, postoperative course and oncological outcome, the surgical method for LRN can be selected according to characteristics of each surgical method.

UR - http://www.scopus.com/inward/record.url?scp=40349087449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40349087449&partnerID=8YFLogxK

M3 - Article

C2 - 18186294

AN - SCOPUS:40349087449

VL - 98

SP - 389

EP - 396

JO - Fukuoka Acta Medica

JF - Fukuoka Acta Medica

SN - 0016-254X

IS - 11

ER -